• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by The Pennant Group Inc. (Amendment)

    2/14/24 10:04:40 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email
    SC 13G/A 1 pntg13gadec23.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) PENNANT GROUP INC/THE (Name of Issuer) COMMON STOCK (Title of Class of Securities) 70805E109 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 996,671 6. Shared Voting Power* 0 7. Sole Dispositive Power* 2,718,886 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 2,718,886 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 9.1% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: PENNANT GROUP INC/THE Item 1(b) Address of Issuer's Principal Executive Offices: 1675 E. RIVERSIDE DRIVE, SUITE 150, EAGLE, IDAHO 83616 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 70805E109 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. (2) [T. ROWE PRICE SMALL-CAP VALUE FUND ]: T. ROWE PRICE SMALL-CAP VALUE FUND, of which T. Rowe Price Investment Management, Inc. is the investment adviser, holds the securities reported herein in their investment portfolio managed by T. Rowe Price Investment Management, Inc. and such funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that they hold. T. ROWE PRICE SMALL-CAP VALUE FUND has an interest in 1,676,162 of the class reported herein representing 5.6% of the class. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: February 14, 2024 Signature: /s/ Armando Capasso Name & Title: Armando Capasso, Vice President 12/31/2023
    Get the next $PNTG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    6/21/2022$23.00 → $17.00Overweight → Equal-Weight
    Stephens
    3/10/2022$37.00 → $26.00Outperform
    RBC Capital
    3/2/2022$33.00 → $26.00Overweight
    Stephens & Co.
    3/1/2022$32.00 → $18.00Buy → Hold
    Stifel
    More analyst ratings

    $PNTG
    Leadership Updates

    Live Leadership Updates

    See more
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

      EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company. Mr. Guerisoli has served on Pennant's board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2

      1/2/25 4:23:29 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Appoints Lynette Walbom as Chief Financial Officer

      EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou

      5/22/23 4:05:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Pennant Reports First Quarter 2025 Results

      EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). First Quarter Highlights Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;Adjusted net income

      5/6/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Announces First Quarter 2025 Earnings Release and Call

      EAGLE, Idaho, April 21, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its first quarter 2025 financial results on Tuesday, May 6, 2025. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during which Pennant's management will discuss its first quarter results. To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the In

      4/21/25 4:27:05 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Stringfield Joanne sold $17,037 worth of shares (665 units at $25.62), decreasing direct ownership by 2% to 30,275 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      5/5/25 9:35:42 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Chief Operating Officer Gochnour John J exercised 6,286 shares at a strike of $7.42, increasing direct ownership by 5% to 134,250 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      5/1/25 6:45:13 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Director Nackel John G. was granted 1,900 shares, increasing direct ownership by 1% to 165,065 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      4/17/25 5:39:12 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/14/24 1:28:33 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:30:29 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by The Pennant Group Inc.

      SC 13G - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:12:22 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Pennant Group with a new price target

      Wells Fargo initiated coverage of Pennant Group with a rating of Equal Weight and set a new price target of $33.00

      12/19/24 8:23:12 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stephens with a new price target

      Stephens upgraded Pennant Group from Equal-Weight to Overweight and set a new price target of $18.00 from $14.00 previously

      1/5/24 8:40:53 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stifel with a new price target

      Stifel upgraded Pennant Group from Hold to Buy and set a new price target of $16.00 from $15.00 previously

      2/27/23 7:37:38 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    SEC Filings

    See more
    • The Pennant Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Pennant Group, Inc. (0001766400) (Filer)

      5/20/25 4:08:35 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by The Pennant Group Inc.

      10-Q - Pennant Group, Inc. (0001766400) (Filer)

      5/6/25 4:12:39 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Pennant Group, Inc. (0001766400) (Filer)

      5/6/25 4:10:35 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Financials

    Live finance-specific insights

    See more
    • Pennant Reports First Quarter 2025 Results

      EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). First Quarter Highlights Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;Adjusted net income

      5/6/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

      EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant's Arizona operations by 128 units. "This acquisition aligns with our mission to provide life-changing service as we create active, supportive communities where seniors can thrive," said Brent Guerisoli, Chief Executive Officer of Pennant. "By expanding our services and adding

      4/1/25 4:53:37 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Reports Fourth Quarter and Fiscal Year 2024 Results

      Conference Call and Webcast scheduled for tomorrow, February 28, 2025 at 10:00 am MT EAGLE, Idaho, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the fiscal year and fourth quarter of 2024, reporting GAAP diluted earnings per share of $0.70 and $0.16 for the year ended December 31, 2024 and the fourth quarter, respectively. Pennant also reported adjusted diluted earnings per share of $0.94 for the year and $0.24 for the quarter (1). Fourth Quarter Highlights Total revenue for the full year was $695.2 million, an

      2/27/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care